The IC/BPS patients with successful outcomes had significantly lower levels of tumor necrosis factor-α (TNF-α) in their PRP than those with unsuccessful outcomes (p = 0.041). The gene discussed is TNF; the disease is Bartsocas-Papas syndrome 1.